PAPILLARY ADENOCARCINOMA OF THE LUNG
Main Article Content
Siti Aisyah
Lely Hartati
Amiruddin
Background : Lung cancer is the most common cause of cancer deaths worldwide. Mortality and incidence rates are generally highest in high-income countries, especially the United States and European countries. In the United States, it is estimated that 234,030 people were diagnosed with lung cancer in 2018. Adenocarcinoma is the most dominant type of histological lung cancer, with the papillary adenocarcinoma subtype rarely encountered.Case Report : A case was reported from a 66-year-old male with slaid number B / 4903/19. On macroscopic examination from biopsy tissue appeared gray, springy, with a volume of ± 0.2 cc. On microscopic examination, a tumor mass shows form a papillary structure with fibrovascular core and a small portion of solid. Consists of tumour cells with pleomorphic nuclei, rough chromatin, some with intranuclear vacuole, pale cytoplasm and protruding nuclei. Mitotic was found. Stroma consists of fibrous connective tissue infiltrated by tumor cells and inflammation of lymphocyte cells. Dilated blood vessels and congestion. Areas of necrosis and lymphovascular invasion were seen.Discussion and Conclusions : Based on the histopathological picture, the patient is diagnosed with papillary adenocarcinoma of the lung with a classical histology picture that makes it easy to established the diagnosis. Prognose was poor.
Travis WD, Noguchi M, Yatabe Y, et al. Adenocarcinoma. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, editors. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th edition. Lyon: IARC; 2015. p.26-50
Patricia M. de Grooth, Carol C. Wu, Brett W. Carter, Reginald F. Munden. Department of Diagnostic Radiology ; The epidemiology of lung cancer ; Wake Forest Baptist Hospital ; NC, USA ; 2018 ; 7 (3) : 220-223
Julie A. Barta, Charles A. Powell, Juan P. Wisnivesky ; Division of Pulmonary and Critical Care Medicine ; Global epidemiologi of lung cancer ; Jefferson University ; US ; available in PMC 2019 september 04
The Global Cancer Observatory ; International Agency for Research on Cancer ; Source: Globocan 2018 ; Indonesia ; may, 2019 Lung Tumor Adenocarcinoma Classification.Available at :http://www.pathologyoutlines.com/topic/lungtumoradenoclass.html
M. Solis Luisa, Behrens C, Raso M.G, Lin H.Y, Kadara H, Yuan P ; Histological pattern and molecular characteristics of lung adenocarcinoma associated with clinical outcome ; Department of Thoracic / Head and Neck Medical Oncology ; Houston : Texas ; 2012Lung Tumor Adenocarcinoma Papillary Subtype. Available at :https://www.pathologyoutlines.com/topic/lungtumorpapillaryadeno.html
Soeroso N, Tarigan SP, Soeroso L. Kanker Paru Diagnosis dan Penatalaksanaan. Medan;USU Press 2017.
Weissferdt A, Moran CA ; Diagnostic Pathology of Pleuropulmonary Neoplasia ; Springer ; New York : London ; 2012 p. 53-90
Kerr M.K ; Department of phatology ; Pulmonary adenocarcinoma : classification a nd reporting ; university medical school ; 2009 ; p. 12-27
William D. Travis, Elisabeth Brambilla, Andrew G. N, Noguchi M, Yatabe Y, John H. M. Austin, et al ; Journal of Thoracic Oncology; The 2015 world Health Organization Classification of Lung Tumors, Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification; STATE OF THE ART: CONCISE REVIEW; 2015. p.1251-1243Lung adenocarcinomm overview . available at : https://www.pathologyoutlines.com/topic/lungtumoradenocarcinoma.html
